5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Mono Pharmacare Ltd.

•
monopharmacareltd.comBSE: -NSE: MONOPHARMA
Market Cap₹ 16 Cr.
Current Price
High / Low₹ 26 / 8
Stock P/E44.8
Book Value₹ 18
Price to Book1.31
Dividend Yield0.00 %
ROCE11.0 %
ROE10.5 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence
78%
View full sector analysis →

PROS

  • Company converts assets efficiently - asset turnover of 1.8x

CONS

  • Company has a high debt-to-equity of 1.72x
  • Operating cash flow has been negative in recent years
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -6.52x)
  • Company has a low return on capital employed of 8.1%
  • Company has a low return on equity of 9.2% over last 3 years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.ADANIENT3057.1055.59413846.540.04-1461.54-249.6732923.9849.9213.3015.57
2.AEGISLOG1353.1037.9647493.810.64544.84210.702356.8637.0719.7630.28
3.CPPLUS3830.1594.9445310.840.04142.20332.511402.4289.5129.4814.52
4.PREMIERENE974.5526.5744239.840.10471.9253.322462.5935.2533.7229.03
5.REDINGTON393.6518.0930774.551.52453.4994.6534922.4734.5718.962.03
6.HONASA470.9561.7015354.110.6490.45118.87755.9527.0020.8714.58
7.LLOYDSENT69.7994.8810653.810.21109.98-55.77563.0370.1512.8418.07
8.SGMART751.2576.169468.390.00455.801310.7113085.701044.0810.434.49
9.MMTC61.9620.789294.000.00104.24135.520.68-50.0033.46-1423.53
10.ENTERO1819.3563.147918.370.0052.0572.171940.5038.2310.935.00
11.EBGNG683.0054.677786.990.0028.9356.21412.4632.0820.5811.97
12.MONOPHARMA8.9544.8015.810.00————11.00—
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

No quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023Mar 2024Mar 2025
27122168
25116161
Operating Profit268
OPM %5.61%5.17%4.54%
001
Interest134
Depreciation000
Profit before Tax134
Tax %24.54%23.78%30.41%
Net Profit123
EPS0.711.381.75
Dividend Payout %0.00%0.00%0.00%

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
-62%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
9%
Last Year:
10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2023Mar 2024Mar 2025
Equity Capital121818
11014
404154
Trade Payables71019
226
Total Liabilities6381110
111
100
334255
03242
Cash & Bank001
28611
Total Assets6381110

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023Mar 2024Mar 2025
-28-9-4
Cash from Investing-10-0
Cash from Financing3085
0-00

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025
56.7256.7256.7256.7256.7256.72
FIIs0.000.000.000.000.000.00
DIIs0.000.000.000.000.000.00
Government0.000.000.000.000.000.00
43.2843.2743.2843.2843.2843.28

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for MONOPHARMA

Loading news…

🤖

AI Stock Analyst

Mono Pharmacare Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login